Archives

Webinar: Bead-Based Assays Detect Antibiotics in Livestock

October 3rd, 2018 / Christine Valle

Scientists use multiplexing technology to look for dozens of antibiotic signatures At the RIKILT institute at Wageningen University & Research in The Netherlands, the mission is “safe and reliable food for everyone” — which is why scientists are diligently developing new tests to assess the health of livestock. In this video presentation, researcher Jeroen Peters

Continue reading »

At the Serum Institute of India, Vaccine Development Requires Multiplex Assays

September 25th, 2018 / Hilary Graham

Bonus: Pro tips for xMAP® assay developers Since 1967, the Serum Institute of India has launched more than 20 vaccines, with five more vaccines in the pipeline specifically designed to target infectious diseases that are prevalent in developing countries. Impressively, the institute has produced more than 1.3 billion high-quality, low-cost vaccine doses. The team there

Continue reading »

Multiplex Test Reveals Molecular Subtypes of Breast Cancer

September 18th, 2018 / Hilary Graham

Video protocol shows how to get robust results even from FFPE and other challenging samples Sometimes there’s nothing better than watching someone else perform a protocol to understand how it’s done. That’s the concept behind JoVE, or the Journal of Visualized Experiments, which is kind of like YouTube for scientific techniques. In a new video

Continue reading »

Webinar: Kidney Function Study Suggests Biomarkers Associated with IgA Nephropathy

September 5th, 2018 / Hilary Graham

xMAP® multiplex assays were used to interrogate samples In work powered in part by Luminex’s xMAP® Technology, scientists have uncovered promising biomarkers that may signal the loss of renal function in people with IgA nephropathy, the most common form of glomerulonephritis. In this 10-minute video presentation, David Wimbury from the University of Leicester shares experimental

Continue reading »

Webinar: xMAP® Technology Drives Development of Prostate Cancer Detection Assay

August 8th, 2018 / Hilary Graham

Better test accuracy reduces the need for invasive biopsy procedures For a startup company striving to deliver diagnostics that improve health care for patients who may have prostate cancer, Luminex’s xMAP® Technology is a critical tool in the assay development process. According to a webinar presentation from Ramy Huber, a research associate at ProteoMediX, the assay

Continue reading »

Webinar Wednesday: For Tracking Anti-Apoptosis Proteins, Scientists Turn to Multiplexing

July 25th, 2018 / Hilary Graham

AbbVie team uses Luminex-based immunoassay for drug discovery applications According to Dr. Lloyd Lam, a senior scientist at AbbVie, measuring the expression of anti-apoptotic proteins such as BCL-2 is an easier and more cost-effective task when done with a multiplex immunoassay. Lam spoke in a Nature webinar entitled “Multiplex assays of the anti-apoptotic BCL-2 family,”

Continue reading »

How to Multiplex Analysis of Autoimmune Biomarkers

July 11th, 2018 / Hilary Graham

At Protagen, scientists enlist xMAP® Technology to characterize autoantibodies Multiplex analysis of autoantibodies is an effective way to understand autoimmune disease, discover important biomarkers, and stratify patients into subgroups, according to Hans-Dieter Zucht, Head of Technology at Protagen. The company uses a biomarker discovery platform for autoimmune disease and immuno-oncology applications. In a presentation about autoantibody

Continue reading »

Webinar Wednesday: Immunoassay Multiplexing Master Class

June 20th, 2018 / Hilary Graham

From assay development to workflow protocols, how to run a multiplex immunoassay If you could run in 3 hours an immunoassay workflow that would normally take more than 60 hours, that wouldn’t be a tough decision, would it? A step-by-step tutorial webinar from Brett Houser at Bio-Rad shows you exactly how to make that transition.

Continue reading »

xMAP® Assays Reveal More About Immune Response than Traditional Vaccine ELISAs

May 30th, 2018 / Hilary Graham

Serotype-specific assays pinpoint threshold values missed by standard tests If you use ELISAs to test immunological responses, Siân Faustini from the University of Birmingham has this advice: “Serotype-specific assays are the way to go.” In her 20-minute webinar presentation from xMAP® Connect 2017, “Exploring immunological assays to assess responses to pneumococcal polysaccharide and conjugate vaccines

Continue reading »

Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development

April 18th, 2018 / Hilary Graham

Paul Rhyne from BDS Shares Recommended Multiplexing Techniques Paul Rhyne, PhD, Chief Scientific Officer at Biologic Development Services (BDS), shares insights from a review article co-authored with 11 colleagues from pharmaceutical companies, clinical research organizations (CRO), and government agencies over two years titled: Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in

Continue reading »